Antibody-Mediated Rejection Treatment With Bortezomib in Renal Transplant Recipients: A Single-Center 24-Month Follow-up Case Report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antibody-Mediated Rejection Treatment With Bortezomib in Renal Transplant Recipients: A Single-Center 24-Month Follow-up Case Report

Published:2020-05 Issue:4 Volume:52 Page:1123-1126
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Bahena Méndez J.,López y López L.R.,Sebastián Díaz M.A.,Trejo Curiel I.,Galindo-Lopéz R.,Baca Córdova A.,Wasung de Lay M.,Vázquez Dávila R.A.,Zarate Rodríguez P.A.,Carmona-Escamilla M.A.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference17 articles.

1. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease.;Kidney Int Suppl,2013

2. The KDIGO clinical practice guidelines for the care of kidney transplant recipients;Chapman;Transplantation,2010

3. Antibody-mediated rejection of solid-organ allografts;Loupy;N Engl J Med,2018

4. Differential outcomes in 3 types of acute antibody-mediated rejection;Rafiq;Clin Transplant,2009

5. Proteasome inhibitor-based therapy for antibody-mediated rejection;Carlin Walsh;Kidney Int,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of bortezomib in the treatment of active antibody-mediated rejection in adult kidney-transplant recipients: A single-center retrospective study;Indian Journal of Transplantation;2022

2. Rejection Challenges: Diagnosis and Management;Challenges in Pediatric Kidney Transplantation;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP